Josephin Wagner

6PUBLICATIONS
12CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Metabolic medicinePharmacogenomicsGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 09, 2026
PCSK9 as an Emerging Target for Cerebrovascular Dysfunction and Neuroinflammation in Ischemic Stroke.

|Mar 04, 2026
Alcohol Use Disorder With Metabolic Dysfunction Is Associated With Adverse Health Impacts in a United States Clinical Setting.

Alexandra C Wagner, Jeesun Jung, Joshua Reitz

|Sep 10, 2025
Genetically modeled GLP1R and GIPR agonism reduce binge drinking and alcohol-associated phenotypes: a multi-ancestry drug-target Mendelian randomization study.

Joshua Reitz, Daniel B Rosoff, Tyler Perlstein

|Nov 11, 2024
A multi-omics Mendelian randomization study identifies new therapeutic targets for alcohol use disorder and problem drinking.

Daniel B Rosoff, Josephin Wagner, Andrew S Bell

|Jan 23, 2024
Evaluating the Cardiovascular Impact of Genetically Proxied PCSK9 and HMGCR Inhibition in East Asian and European Populations: A Drug-Target Mendelian Randomization Study.

Daniel B Rosoff, Andrew S Bell, Lucas A Mavromatis

|Oct 26, 2022
Comparing the Relationships of Genetically Proxied PCSK9 Inhibition With Mood Disorders, Cognition, and Dementia Between Men and Women: A Drug-Target Mendelian Randomization Study.

Andrew S Bell, Daniel B Rosoff, Lucas A Mavromatis

Pageof 1

Frequent Collaborators

5 joint publications

Falk W Lohoff

4 joint publications

Jeesun Jung

3 joint publications

Lucas A Mavromatis

2 joint publications

Andrew S Bell